Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B F McGraw

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Drug Targeting|February 22, 2000
Commentary on the challenges of establishing gene medicines as a new class of therapeuticsB F McGraw
Drug Intelligence & Clinical Pharmacy|May 1, 1982
Diltiazem hydrochlorideB F McGraw
American Journal of Optometry and Physiological Optics|December 1, 1978
Methods for increasing bioavailability of cycloplegicsB F McGraw, C L Rollins
Drug Intelligence & Clinical Pharmacy|July 1, 1981
SucralfateB F McGraw, E G Caldwell
Acta Pharmacologica Et Toxicologica|January 1, 1985
Interpretation and application of world-wide safety data on diltiazemM A Quigley, K L White, B F McGraw
Research Communications in Chemical Pathology and Pharmacology|November 1, 1980
Does basic aluminum sucrose sulfate affect blood coagulability?B F Mcgraw, E J Hesterlee, S L Gitomer, et al.
The American Journal of Gastroenterology|November 1, 1981
In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiulcer agentB F McGraw, E J Hesterlee, F L Lanza, et al.
Clinical Pharmacology and Therapeutics|September 1, 1981
Variability of exercise performance during long-term placebo treatmentB F McGraw, J A Hemberger, A L Smith, et al.
Pharmacotherapy|May 1, 1982
Clinical experience with diltiazem in JapanB F McGraw, S D Walker, J A Hemberger, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Drug Targeting|February 22, 2000
Commentary on the challenges of establishing gene medicines as a new class of therapeuticsB F McGraw
Drug Intelligence & Clinical Pharmacy|May 1, 1982
Diltiazem hydrochlorideB F McGraw
American Journal of Optometry and Physiological Optics|December 1, 1978
Methods for increasing bioavailability of cycloplegicsB F McGraw, C L Rollins
Drug Intelligence & Clinical Pharmacy|July 1, 1981
SucralfateB F McGraw, E G Caldwell
Acta Pharmacologica Et Toxicologica|January 1, 1985
Interpretation and application of world-wide safety data on diltiazemM A Quigley, K L White, B F McGraw
Research Communications in Chemical Pathology and Pharmacology|November 1, 1980
Does basic aluminum sucrose sulfate affect blood coagulability?B F Mcgraw, E J Hesterlee, S L Gitomer, et al.
The American Journal of Gastroenterology|November 1, 1981
In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiulcer agentB F McGraw, E J Hesterlee, F L Lanza, et al.
Clinical Pharmacology and Therapeutics|September 1, 1981
Variability of exercise performance during long-term placebo treatmentB F McGraw, J A Hemberger, A L Smith, et al.
Pharmacotherapy|May 1, 1982
Clinical experience with diltiazem in JapanB F McGraw, S D Walker, J A Hemberger, et al.
Pageof 1